Do We Need to Perform Control Angiography in Patients Undergoing Percutaneous Coronary Intervention After Tirofiban Infusion?
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31445 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Gülden Güven und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Basaksehir Cam & Sakura City Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Tirofiban, Percutaneous Coronary Intervention, Coronary Angiography, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objective
The aim of this study was to investigate the effect of control imaging after intravenous (IV) tirofiban infusion on the clinical outcome of patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).
Methods
Patients who underwent PCI between June 2020 and October 2023 at our tertiary referral hospital and received tirofiban infusion were analyzed. Primary composite endpoint was the combination of cardiovascular death, myocardial infarction, cerebrovascular accident, or unplanned revascularization during follow‐up.
Results
A total of 217 patients (22.6% female, mean age: 58 ± 13 years) with ACS who received IV tirofiban therapy after PCI were compared in three groups: Patients without additional procedure ( n = 131), patients undergoing control coronary angiography after index PCI ( n = 43), and patients undergoing additional PCI after index PCI ( n = 43). The most common reason for clinical intervention was STEMI (65.9%). After approximately 1 year of follow‐up, primary composite endpoint of cardiac death, myocardial infarction, cerebrovascular accident, or unplanned revascularization was similar in all groups (30 [22.9%] vs. 15 [35%] vs. 12 [28%], p = 0.290).
Conclusion
Repeat coronary angiography and additional PCI after tirofiban infusion in patients undergoing index PCI were associated with similar cardiovascular outcomes at 1‐year follow‐up compared with no repeat coronary angiography.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Basaksehir Cam & Sakura City Hospital, Istanbul, Turkey.
ORCID-Profile: Gülden Güven
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Güven, G., Çetin, İ., Kılıç, Ş., Acaroğlu, Ş., Aslanger, K. E., & Sonsöz, M. R. (2025). Do We Need to Perform Control Angiography in Patients Undergoing Percutaneous Coronary Intervention After Tirofiban Infusion?. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31445
Vancouver
Güven G, Çetin İ, Kılıç Ş, Acaroğlu Ş, Aslanger KE, Sonsöz MR. Do We Need to Perform Control Angiography in Patients Undergoing Percutaneous Coronary Intervention After Tirofiban Infusion?. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31445
BibTeX
@article{Gven2025,
author = {Güven, Gülden and Çetin, İlyas and Kılıç, Şevval and Acaroğlu, Şeyma and Aslanger, Kartal Emre and Sonsöz, Mehmet Rasih},
title = {Do We Need to Perform Control Angiography in Patients Undergoing Percutaneous Coronary Intervention After Tirofiban Infusion?},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31445}
}
EUVIMED